FDA Takes Its Time Reviewing Generic Drugs

The FDA generally takes longer than the 180-days allowed under federal law to process generic drug applications, a government report released Thursday says, citing, unsurprisingly, the agency’s lack of resources and personnel as a factor. Reviews are convoluted. For starters, when a drug company submits a generic drug application it gets passed around to three […]

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.